Gout Dose Response Study

NCT00955981 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperuricemia

Interventions

DRUG: RDEA594
DRUG: Placebo

Sponsor

Ardea Biosciences, Inc.